Medical Monitor

2 days ago

Durban, KwaZulu-Natal, South Africa BioInformatiCo Full-time

Location: Remote

Expected start date: As soon as possible until July 2029.

JOB PURPOSE

The Medical Monitor provides independent medical and scientific oversight of clinical trials to protect the safety, rights and wellbeing of study participants and to safeguard the scientific integrity of the trial data. The Medical Monitor acts as the primary medical point of contact for investigational sites and the study team, and ensures that the trial is conducted in accordance with the protocol, Good Clinical Practice (GCP), applicable regulations and relevant standard operating procedures (SOPs). As BioInformatiCo is the pharmacovigilance (PV) provider for its trials, the Medical Monitor also performs the study’s PV and drug safety activities on BioInformatiCo’s behalf.

KEY RESPONSIBILITIES

Study start-up and training

  • Become thoroughly familiar with the Investigator’s Brochure (IB), the study protocol and all subsequent amendments
  • Contribute to the development and review of study documents, including the Medical Monitoring Plan and Safety Management Plan
  • Deliver protocol and IB training at Investigators’ Meetings and Site Initiation Visits
  • Provide ongoing medical training to site and project teams as required

Medical oversight and site support

  • Act as the primary medical contact for sites on patient eligibility, protocol interpretation, adverse event grading and causality, drug interactions, and patient rescue and discontinuation
  • Review patient eligibility against the protocol inclusion and exclusion criteria
  • Provide medical oversight of the site project team
  • Be available 24 hours a day, 7 days a week for urgent medical questions, and keep contact details up to date on the study contact list
  • Handle other trial-related medical issues as they arise

Safety monitoring

  • Review all Serious Adverse Events (SAEs), Adverse Events of Special Interest (AESIs) and pregnancy reports within the timelines required by the protocol, the Safety Management Plan and local regulations
  • Request additional or missing safety information from investigational sites and follow up outstanding case queries to resolution
  • Ensure that safety committees (e.g. the Safety Review Team and Data and Safety Monitoring Board) are notified of all SAEs and AESIs

Review Individual Case Safety Report (ICSR) narratives, including those for Suspected Unexpected Serious Adverse Reactions (SUSARs), within prescribed reporting timelines

  • Identify trends in safety data and escalation potential safety signals
  • Serve as a voting member of the Safety Review Team and a non-voting member of the Data and Safety Monitoring Board, as applicable

Pharmacovigilance (on behalf of BioInformatiCo as PV provider)

  • Perform SAE, AESI and pregnancy case processing, including data entry, MedDRA coding, medical assessment and narrative writing in the safety database
  • Assess expectedness against the Reference Safety Information in the IB and identify SUSARs
  • Prepare and submit expedited safety reports (e.g. SUSARs) to regulatory authorities, ethics committees and investigators within regulatory timelines
  • Prepare annual and aggregate safety reports (e.g. Development Safety Update Reports) and contribute safety data to DSMB and Safety Review Team packages
  • Maintain the Safety Management Plan and safety-related procedures for the study
  • Perform periodic and final reconciliation of the safety database against the clinical database
  • Maintain PV documentation and inspection-ready records in line with BioInformatiCo SOPs and applicable regulations

Medical data review

  • Perform regular (e.g. weekly) medical review of cumulative clinical data, either directly in the electronic Case Report Form (eCRF) or via database reports, and raise queries as required
  • Review patient profiles to confirm correct application of stopping criteria, follow-up of patients lost to follow-up, and reasons for early termination or withdrawal
  • Review medical history, physical examination findings and concomitant medications for eligibility, completeness and consistency
  • Review vital signs, ECG and laboratory data for clinically significant changes from baseline, shifts across visits and findings suggestive of an underlying disorder
  • Review efficacy and disease-specific data (e.g. signs and symptoms, diagnostic results) for adherence to protocol criteria
  • Review adverse events for medical appropriateness of verbatim terms, severity grading, causality assessment, action taken, expedited reporting and consistency with other data
  • Review protocol deviations with the project team to assess their impact on patient safety and study outcomes and determine whether corrective and preventive action is re